Vincristine is an antitumor vinca alkaloid isolated from Vinca Rosea. It is marketed under several brand names, many of which have different formulations such as Marqibo (liposomal injection) and Vincasar. Vincristine is indicated for the treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, and acute panmyelosis. vincristin...
Treatment of acute lymphocytic leukemia (ALL), Hodgkin lymphoma, non-Hodgkin lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. Liposomal vincristine is indicated for the treatment of relapsed Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL).
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Universitaetsklinik Innsbruck/ Klinik für Innere Medizin, Innsbruck, Austria
A.ö. Landeskrankenhaus Leoben, Leoben, Austria
Krankenhaus d. Barmherzigen Schwestern Linz, Linz, Austria
Wenatchee Valley Medical Center, Wenatchee, Washington, United States
Park Nicollet Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United States
Facey Medical Group, Mission Hills, California, United States
Centro Trapianti Midollo Osseo, P.O. Businco, Cagliari, Italy
Ospedale S. Gerardo, Monza, Italy
Osp. maggiore della Carità, Novara, Italy
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Ist.Ematologia e Oncologia Medica L.e A. Seragnoli, Bologna, Italy
Ospedale Reg. A di Summa, Brindisi, Italy
Istituto di Ematologia- Ospedale San Carlo, Potenza, Italy
Basurtuko Ospitalea, Basurto, Spain
Complejo Hospitalario Universitario de Albacete, Albacete, Spain
Hospital General de Alicante, Alicante, Spain
Hospital Niño Jesús, Madrid, Spain
Hospital materno Infantil vall d'Hebrón, Barcelona, Spain
Hospital Infantil Carlos Haya, Málaga, Spain
Hospital General de Segovia, Segovia, Spain
Hospital Universitario de Canarias, Tenerife, Spain
H.U. Virgen del Rocio, Sevilla, Spain
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.